Found: 17
Select item for more details and to access through your institution.
PCDH10 is a candidate tumour suppressor gene in medulloblastoma.
- Published in:
- Child's Nervous System, 2011, v. 27, n. 8, p. 1243, doi. 10.1007/s00381-011-1486-x
- By:
- Publication type:
- Article
Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14400, doi. 10.1038/ncomms14400
- By:
- Publication type:
- Article
Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 504, p. 1, doi. 10.1126/scitranslmed.aau4972
- By:
- Publication type:
- Article
The genetic and epigenetic basis of ependymoma.
- Published in:
- Child's Nervous System, 2009, v. 25, n. 10, p. 1195, doi. 10.1007/s00381-009-0928-1
- By:
- Publication type:
- Article
Heterogeneity within the PF-EPN-B ependymoma subgroup.
- Published in:
- Acta Neuropathologica, 2018, v. 136, n. 2, p. 227, doi. 10.1007/s00401-018-1888-x
- By:
- Publication type:
- Article
<i>TERT</i> promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
- Published in:
- Acta Neuropathologica, 2013, v. 126, n. 6, p. 917, doi. 10.1007/s00401-013-1198-2
- By:
- Publication type:
- Article
FoxG1 Interacts with Bmi1 to Regulate Self-Renewal and Tumorigenicity of Medulloblastoma Stem Cells.
- Published in:
- Stem Cells, 2013, v. 31, n. 7, p. 1266, doi. 10.1002/stem.1401
- By:
- Publication type:
- Article
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A functional genomics approach to identify pathways of drug resistance in medulloblastoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Emerging Insights into the Ependymoma Epigenome.
- Published in:
- Brain Pathology, 2013, v. 23, n. 2, p. 206, doi. 10.1111/bpa.12020
- By:
- Publication type:
- Article
Nestin Expression Identifies Ependymoma Patients with Poor Outcome.
- Published in:
- Brain Pathology, 2012, v. 22, n. 6, p. 848, doi. 10.1111/j.1750-3639.2012.00600.x
- By:
- Publication type:
- Article
Therapeutic targeting based on gene-expression profiling in vestibular schwannomas.
- Published in:
- Journal of Neurosurgery, 2014, v. 121, n. 6, p. 1433
- By:
- Publication type:
- Article
Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
- Published in:
- Journal of Neurosurgery, 2014, v. 121, n. 6, p. 1434, doi. 10.3171/2014.6.jns131433
- By:
- Publication type:
- Article
Understanding the mechanisms of diffuse midline glioma cell migration toward therapeutic targeting.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 569, doi. 10.1093/neuonc/noad263
- By:
- Publication type:
- Article
Leveraging epigenomic patterns to resolve the heterogeneity and origins of CNS germ cell tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1259, doi. 10.1093/neuonc/noac102
- By:
- Publication type:
- Article
Highlights from the literature.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 446, doi. 10.1093/neuonc/noaa049
- By:
- Publication type:
- Article
FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii35, doi. 10.1093/neuonc/nou208.47
- By:
- Publication type:
- Article